Trump Signs Executive Order to Fast-Track Psychedelic Drug Research
President Trump signed an executive order to accelerate research, funding, and potential FDA approval for psychedelic drugs like ibogaine. The initiative aims to provide faster access to treatments for conditions such as PTSD, depression, and addiction, with a particular focus on veterans.
Trump Signs Executive Order to Fast-Track Psychedelic Drug Research Story coverage
Referenced event not yet available
nevent1qqsdt…vcj34dv9
Referenced event not yet available
nevent1qqspj…5scpkkr0
Trump signs order to expedite medical psychedelic drug treatment, research President Trump signed an executive order Saturday to fast-track access to medical psychedelic drug research and treatment.
Referenced event not yet available
nevent1qqs2t…xg77ajd4
Referenced event not yet available
nevent1qqsz9…3c5tf853
Referenced event not yet available
nevent1qqst7…dqa34qks
No comments yet.
Write a comment